JP3120922B2 - Chemical injection device - Google Patents
Chemical injection deviceInfo
- Publication number
- JP3120922B2 JP3120922B2 JP05113903A JP11390393A JP3120922B2 JP 3120922 B2 JP3120922 B2 JP 3120922B2 JP 05113903 A JP05113903 A JP 05113903A JP 11390393 A JP11390393 A JP 11390393A JP 3120922 B2 JP3120922 B2 JP 3120922B2
- Authority
- JP
- Japan
- Prior art keywords
- balloon
- chemical
- drug solution
- solution
- inner diameter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は所定量の薬液を体内に注
入するための薬液注入器具に関し、更に詳しくは、バル
−ン内に加圧状態で貯蔵された薬液を、一定速度で患者
に注入することができる薬液注入器具に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a drug solution injection device for injecting a predetermined amount of a drug solution into a body, and more particularly to a drug solution stored under pressure in a balloon to a patient at a constant speed. The present invention relates to a drug solution injector that can be injected.
【0002】[0002]
【従来の技術】従来、抗生物質、抗ガン剤、麻酔剤等の
薬液を血管、膀胱等に少しずつ注入する手段として、弾
性材料からなるバルーンに薬液を収納し、バルーンの収
縮力を利用して薬液を人体に持続注入する器具(特開平
4-67873号公報)が知られている。該公報に記載された
薬液注入器具を図8および図9に示す。図8は該薬液注入
器具の全体説明図であって、穿刺針がハウジングの栓体
に穿刺していない状態を示しており、図9は図8に示すハ
ウジングのバルーンに薬液を充填した時の状態を示す拡
大断面図である。図8および図9の薬液注入器具は、バル
ーン42を収納するハウジング43からなるバルーン部e
と、薬液の流量を調節するための流量制御部44を有する
薬液流出部fとからなっている。バルーン42は図9に示す
棒状内軸45と、該内軸45に滑動自在に外装されてなる円
筒状外軸46と、前記内軸45の一端であって外軸46が外装
される側と反対側の端部に内軸と一体に形成された内軸
受け47と、前記内軸45および外軸46を被覆するようにこ
れら両軸の外部に設けられ、その一端が内軸45に密着固
定され、他端が外軸46に密着固定された弾性材料製バル
ーン42とからなっている。またハウジング43の一端には
薬液出入部であるアダプター48が形成されている。薬液
通路51の端部には栓体49が設置され、バルーン42内部へ
の薬液流入時には注射針で薬液を注入し、バルーン42か
らの薬液流出時には図8の注射針50が栓体49を穿刺する
ことによって、薬液は薬液流出部f端部の接続具52に設
けられた穿刺針(図示せず)から人体に注入される構造
をしている。2. Description of the Related Art Conventionally, as a means for gradually injecting a drug solution such as an antibiotic, an anticancer drug, an anesthetic into a blood vessel, a bladder or the like, a drug solution is housed in a balloon made of an elastic material and the contraction force of the balloon is used. For continuously injecting drug solution into the human body
4-67873) is known. FIGS. 8 and 9 show the drug solution injector described in the publication. FIG. 8 is an overall explanatory view of the drug solution injection device, showing a state in which the puncture needle has not punctured the stopper of the housing, and FIG. 9 shows a state in which the drug solution is filled in the balloon of the housing shown in FIG. It is an expanded sectional view showing a state. 8 and 9 has a balloon portion e including a housing 43 that houses a balloon 42.
And a chemical solution outlet f having a flow rate control unit 44 for adjusting the flow rate of the chemical solution. The balloon 42 has a rod-shaped inner shaft 45 shown in FIG. 9, a cylindrical outer shaft 46 slidably mounted on the inner shaft 45, and one end of the inner shaft 45 on which the outer shaft 46 is mounted. An inner bearing 47 formed integrally with the inner shaft at the opposite end, and provided outside the two shafts so as to cover the inner shaft 45 and the outer shaft 46, one end of which is tightly fixed to the inner shaft 45. The other end is made of an elastic material balloon 42 that is tightly fixed to the outer shaft 46. At one end of the housing 43, an adapter 48 which is a chemical liquid inlet / outlet is formed. At the end of the drug solution passage 51, a stopper 49 is installed, and when the drug solution flows into the balloon 42, the drug solution is injected with a syringe needle, and when the drug solution flows out of the balloon 42, the injection needle 50 of FIG. By doing so, the liquid medicine is configured to be injected into the human body from a puncture needle (not shown) provided in the connector 52 at the end of the liquid medicine outlet f.
【0003】[0003]
【発明が解決しょうとする課題】かかる薬液注入器具
は、バル−ンが大きな変形をしないで一定圧力で薬液を
流出させるために、バル−ン内部に内軸と外軸を設けバ
ル−ンが長軸方向の中心軸に沿って変形するようにし、
更にバル−ン内部の端部に内軸受けを設けることによっ
てバル−ンがハウジングの内壁に沿って変形する構造を
している。しかしながら、かかる薬液注入器具はバル−
ン内部にかかる機構を設けているために薬液注入器具の
小型化が自ずから限定され、患者が携行しながら薬液を
注入する際に問題があった。本発明者はかかる問題を解
決するために鋭意研究した結果、従来薬液を充填したバ
ル−ンの収縮力だけで薬液を人体に注入していたのを、
更にガスの圧力をも加えることによって、簡単な機構で
薬液を人体に注入できることを見出し本発明に到達し
た。In such a liquid injector, the inner shaft and the outer shaft are provided inside the balloon so that the balloon can be discharged at a constant pressure without causing significant deformation of the balloon. So that it deforms along the central axis in the long axis direction,
Further, by providing an inner bearing at the end inside the balloon, the balloon is configured to be deformed along the inner wall of the housing. However, such a drug solution injecting device is
The provision of such a mechanism in the interior of the device limits the downsizing of the drug solution injector naturally, and presents a problem when the patient injects the drug solution while carrying the device. The inventor of the present invention has made intensive studies to solve such a problem, and as a result, it has been found that the conventional method of injecting a drug solution into a human body only by the contraction force of a balloon filled with the drug solution,
Further, the present inventors have found that a chemical solution can be injected into a human body by a simple mechanism by further applying gas pressure, and have reached the present invention.
【0004】[0004]
【課題を解決するための手段】すなわち、本発明は加圧
状態で薬液を貯蔵し、かつ開口部から薬液を流入および
流出させるバルーンと、該バルーンを収納し、バルーン
の外側が薬液を充填したバルーンの圧力より高い圧力で
加圧されたガスが充填されたガス室とからなるハウジン
グと、該ハウジングを形成する壁に設置された前記バル
ーンの開口部を固着した薬液流入部および/または薬液
流出部とガス注入口と、前記薬液流出部から延びた薬液
流通チューブと、該薬液流通チューブに配置された薬液
量を制御するための流量制御部とからなる薬液注入器具
であって、前記流量制御部の薬液上流側には定量弁が設
けられてなる薬液注入器具である。また、本発明は前記
薬液注入器具において、バルーン材料が弾性ゴムまたは
熱可塑性樹脂からなる薬液注入器具である。That is, according to the present invention, a medicinal solution is stored in a pressurized state, and a balloon for inflow and outflow of the medicinal solution from an opening portion, the balloon is housed, and the outside of the balloon is filled with the medicinal solution. A housing composed of a gas chamber filled with a gas pressurized at a pressure higher than the pressure of the balloon, and a chemical inflow portion and / or a chemical solution outflow secured to an opening of the balloon provided on a wall forming the housing. Device, a gas injection port, a drug solution flow tube extending from the drug solution outflow portion, and a drug solution injection device comprising a flow rate control portion for controlling the amount of the drug solution arranged in the drug solution flow tube.
A fixed quantity valve is provided upstream of the chemical solution of the flow control unit.
It is a drug solution injection device that is made. Further, the present invention is the above-mentioned drug solution injector, wherein the balloon material is made of elastic rubber or thermoplastic resin.
【0005】更にまた、本発明は前記薬液注入器具にお
いて、定量弁は、内径が変形可能な弁孔を有するゴム状
弾性体からなるオリフィス体と、該弁孔の内径を調整す
るための調整手段とからなる薬液注入器具である。ま
た、本発明は前記薬液注入器具において、ハウジングに
おけるガス室の占める体積は、人体に注入すべき薬液量
の薬液を充填させたときのバルーンの占める体積の少な
くとも0.2倍である薬液注入器具である。更に、本発明
は前記薬液注入器具において、流量制御部は、内径10〜
500μの微細内径のパイプからなる薬液注入器具であ
る。更にまた、本発明は前記薬液注入器具において、定
量弁のオリフィス体の弁孔の内径は、薬液上流側の最小
位置から薬液下流側に行くに従って次第に大きくなる薬
液注入器具である。また、本発明は前記薬液注入器具に
おいて、定量弁の弁孔の内径を調整するための調整手段
は、オリフィス体を配設した筒状体の薬液上流側の内壁
に形成された螺子部と、前記弁孔入口と連通するための
薬液上流側通路を有する栓体の外壁に形成された螺子部
とが螺合されてなる薬液注入器具である。Further, according to the present invention, in the liquid injector, the metering valve may be an orifice body made of a rubber-like elastic body having a valve hole whose inner diameter is deformable, and an adjusting means for adjusting the inner diameter of the valve hole. This is a drug solution injection device comprising: Further, in the present invention is the liquid injection device, the volume occupied by the gas chamber in the housing, at least <br/> Kutomo 0.2 times the volume occupied by the balloon when is filled with chemical solution amount of liquid medicine to be injected into the human body This is a certain drug injection device. Further, the present invention provides the drug solution injection device, wherein the flow control unit has an inner diameter of 10 to
This is a drug solution injection device consisting of a pipe with a fine inner diameter of 500μ. Still further, the present invention is the chemical injection device, wherein the inner diameter of the valve hole of the orifice body of the metering valve gradually increases from the minimum position on the upstream side of the chemical to the downstream side of the chemical. Also, the present invention provides the liquid medicine injection device, wherein the adjusting means for adjusting the inner diameter of the valve hole of the metering valve.
Is a screw portion formed on the inner wall of the cylindrical body on which the orifice body is disposed, on the upstream side of the chemical solution, and a screw portion formed on the outer wall of the plug body having a chemical solution upstream passage for communicating with the valve hole inlet. Is a screwed-in liquid injector.
【0006】[0006]
【作用】本発明は薬液をバル−ン内に充填して膨張した
バル−ンの外側から、該バル−ンの収縮力より大きいガ
ス圧でバル−ンを圧縮することによってバル−ン内の薬
液は薬液流通チュ−ブを経て患者に注入される。バル−
ン内の薬液の患者への注入速度は薬液流通チュ−ブに設
置された流量制御部によって制御される。According to the present invention, a balloon is filled with a chemical solution and compressed from the outside of the balloon with a gas pressure greater than the contraction force of the balloon, thereby compressing the balloon. The medicinal solution is injected into the patient via the medicinal solution distribution tube. Bal
The rate of infusion of the drug solution into the patient is controlled by a flow rate control unit installed in the drug solution flow tube.
【0007】[0007]
【実施例】以下実施例で本発明の薬液注入器具の一例を
説明する。図1は本発明の薬液注入器具の一実施例の説
明図、図2は図1のバル−ンに薬液を充填したときのバ
ル−ン部の拡大断面図、図3は図1に示す薬液流通チュ
−ブのコネクタ−とルア−テ−パ−状アダプタ−の拡大
断面図、図4は図3に示すコネクタ−をルア−テ−パ−
状アダプタ−に挿入したときの状態を示す説明図、図5
はシリンジ内薬液をバル−ンに流入させるときの説明図
であってシリンジとバル−ン部が接続していない状態を
示す説明図、図6は図5に示すシリンジから薬液をバル
−ン内へ充填しているときの説明図、図7は流量制御部
の薬液上流側チュ−ブに定量弁を配設した流量制御部付
近の説明図、図8は特開平4-67873号公報に記載されて
いる薬液注入器具の全体説明図、図9は図8に示すハウ
ジングのバル−ンに薬液を充填した時の状態を示す拡大
断面図である。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS An embodiment of the present invention will be described below with reference to the accompanying drawings. FIG. 1 is an explanatory view of an embodiment of a drug solution injection device according to the present invention, FIG. 2 is an enlarged sectional view of a balloon portion when a balloon is filled with a drug solution, and FIG. 3 is a drug solution shown in FIG. FIG. 4 is an enlarged sectional view of a connector of a distribution tube and a luer taper adapter. FIG. 4 shows a luer taper of the connector shown in FIG.
FIG. 5 is an explanatory view showing a state when inserted into a shape adapter.
FIG. 6 is an explanatory view showing a state in which the syringe is not connected to the balloon portion when the chemical solution in the syringe is caused to flow into the balloon. FIG. 6 is a diagram showing a state in which the chemical solution is injected into the balloon from the syringe shown in FIG. FIG. 7 is an explanatory view showing the vicinity of a flow rate control section in which a fixed quantity valve is disposed in a tube upstream of a chemical solution of the flow rate control section, and FIG. 8 is described in JP-A-4-67873. FIG. 9 is an enlarged cross-sectional view showing a state where the balloon of the housing shown in FIG. 8 is filled with a chemical solution.
【0008】図中、aはバルーン部、bは薬液流通チュー
ブ部、1および42はバルーン、2および43はハウジング、
3はガス注入部、4は薬液流出入部、5および44は流量制
御部、6はコネクター部、7はチューブ、8および52は接
続具、9はガス室、10は定量弁、11はロックアダプタ
ー、12は連通パイプ、14は逆止弁、30はオリフィス体、
31は弁孔、32は筒状体、33は栓体、34は雌型螺子部、35
は雄型螺子部、36はキャップ体、37はフィルターを示
す。In the figure, a is a balloon portion, b is a drug solution flowing tube portion, 1 and 42 are balloons, 2 and 43 are housings,
3 is a gas injection part, 4 is a chemical liquid inflow / outlet part, 5 and 44 are flow rate control parts, 6 is a connector part, 7 is a tube, 8 and 52 are fittings, 9 is a gas chamber, 10 is a metering valve, and 11 is a lock adapter. , 12 is a communication pipe, 14 is a check valve, 30 is an orifice body,
31 is a valve hole, 32 is a cylindrical body, 33 is a plug, 34 is a female screw part, 35
Indicates a male screw portion, 36 indicates a cap body, and 37 indicates a filter.
【0009】図1において、薬液注入器具はバル−ン部
aと薬液流通チュ−ブbとから構成されている。バル−
ン部aは図2に示すようにハウジング2の内部に薬液が
収容されたバル−ン1と該バル−ンの収縮力より大きい
圧力を有するガスが充填されたガス室9とからなり、薬
液を人体の注入箇所へ移動せしめる駆動部分である。バ
ル−ン1は口部が薬液流出入部4と液密に固着した一端
が閉じられた円筒状または球状の形状をしており、コネ
クタ−部6から薬液を充填することによって膨張する。
円筒状のバル−ンでは半径方向とともに長手方向にも膨
張しうる構造になっている。バル−ン1は、患者への薬
液注入量、注入時間などに応じて種々の大きさ、肉厚の
ものを用いることができ、本発明においては特に限定さ
れるものでない。In FIG. 1, the chemical liquid injection device comprises a balloon portion a and a chemical liquid distribution tube b. Bal
As shown in FIG. 2, the valve portion a comprises a balloon 1 in which a chemical solution is accommodated in a housing 2 and a gas chamber 9 filled with a gas having a pressure greater than the contraction force of the balloon. Is a drive part for moving the to the injection point of the human body. The balloon 1 has a cylindrical or spherical shape with its one end closed and one end closed in a liquid-tight manner with the chemical solution inflow / outflow portion 4, and expands when a chemical solution is filled from the connector portion 6.
The cylindrical balloon has a structure capable of expanding in the longitudinal direction as well as in the radial direction. The balloon 1 can be of various sizes and thicknesses depending on the amount of the drug solution injected into the patient, the injection time, and the like, and is not particularly limited in the present invention.
【0010】バル−ン1の材料としては弾性ゴムまたは
熱可塑性樹脂が挙げられる。弾性ゴムとしてはシリコ−
ンゴム、ブチルゴム、アクリロニトリルブタジェンゴ
ム、ブタジェンゴム、イソプレンゴム、ウレタンゴム、
スチレンブタジェンゴム、ペルプレン、クレイトンゴム
などの弾性重合体または天然ゴム、これらの重合体混合
物、またはこれらの物質の添加剤を除去したのち人体に
無害の酸化防止剤を添加した加工物質、またはラミネ−
ト等が挙げられる。また、熱可塑性樹脂としては、ポリ
エチレン、ポリプロピレン、ポリ塩化ビニル、ポリエス
テル、ポリアミド等の未延伸、1軸延伸または2軸延伸
フイルムが挙げられる。The material of the balloon 1 includes an elastic rubber or a thermoplastic resin. Silicone as elastic rubber
Rubber, butyl rubber, acrylonitrile butadiene rubber, butadiene rubber, isoprene rubber, urethane rubber,
Elastic polymers or natural rubbers such as styrene-butadiene rubber, perprene, and Clayton rubber, or mixtures of these polymers, or processed substances containing antioxidants that are harmless to the human body after removing additives of these substances, or laminating −
And the like. Examples of the thermoplastic resin include unstretched, uniaxially stretched and biaxially stretched films of polyethylene, polypropylene, polyvinyl chloride, polyester, polyamide and the like.
【0011】バル−ン1の口部はハウジング2の壁部に
固着形成された薬液流出入部4とO−リング17によって
液密に固着され、コネクタ−部6を介して薬液流通チュ
−ブbと連通するようになっている。ハウジング2の壁
部の適宜の箇所には、圧力ガスを注入するためのガス注
入部3が設置されており、ハウジング2内に充填された
圧力ガスが外部に逃散しないように、例えばブチルゴム
等のガス遮断性ゴム栓が設置されている。すなわち、穿
刺針をゴム栓に穿刺して圧力ガスをハウジング2内に注
入し、穿刺針をゴム栓から抜刺後ゴム栓によって圧力ガ
スをハウジング内に保持するとともに、圧力ガスはバル
−ン1内の薬液を人体に注入するための駆動力になる。
ガスとしては空気あるいは窒素ガスのような不活性ガス
が使用される。The mouth of the balloon 1 is fixed in a liquid-tight manner by an O-ring 17 and a chemical liquid inflow / outflow part 4 fixedly formed on a wall of the housing 2 and a chemical liquid distribution tube b via a connector part 6. It has come to communicate with. A gas injection unit 3 for injecting a pressure gas is provided at an appropriate position on a wall of the housing 2. For example, butyl rubber or the like is used to prevent the pressure gas filled in the housing 2 from escaping to the outside. Gas barrier rubber stopper is installed. That is, the pressure gas is injected into the housing 2 by piercing the puncture needle into the rubber stopper, the puncture needle is punctured from the rubber stopper, and the pressure gas is held in the housing by the rubber stopper. It becomes the driving force for injecting the liquid medicine in the human body.
As the gas, air or an inert gas such as nitrogen gas is used.
【0012】ハウジング2におけるガス室9の占める体
積は人体に注入すべき薬液量の薬液を充填させたときの
バルーン1の占める体積の少なくとも0.2倍、好ましくは
0.5〜1.0倍である。ガス室9の占める体積がバルーン1の
占める体積の0.2倍未満であると、薬液を人体に持続し
て注入するためのガス室の圧力が高くなりすぎる傾向が
ある。ガス室の圧力はバルーン材料、バルーン内の薬液
量等によって異なるが、通常は60mmHg以上、好ましくは
100〜1500mmHgである。その他に、ハウジング2はバルー
ン1が外部の鋭利な物体に触れて破損するのを防止する
とともに、バルーン自体のピンホールなどの欠陥によっ
てバルーン1から液洩れが発生した場合に外部に薬液が
飛散しないように薬液を密封する機能をも果たすもので
ある。The volume occupied by the gas chamber 9 in the housing 2 is at least 0.2 times, preferably , at least 0.2 times the volume occupied by the balloon 1 when the amount of the medicinal solution to be injected into the human body is filled.
It is 0.5 to 1.0 times. When the volume occupied by the gas chamber 9 is less than 0.2 times the volume occupied by the balloon 1, there is a tendency that the pressure of the gas chamber for injecting sustained the drug solution to the human body is too high. The pressure of the gas chamber varies depending on the balloon material, the amount of the drug solution in the balloon, and the like, but is usually 60 mmHg or more, preferably
It is 100-1500mmHg. In addition, the housing 2 prevents the balloon 1 from being damaged by touching an external sharp object, and does not scatter the chemical solution to the outside when a leak occurs from the balloon 1 due to a defect such as a pinhole of the balloon itself. In this way, it also has a function of sealing the chemical solution.
【0013】ハウジング2の一端面はキャップ13により
閉じられており、該キャップ13の中央部分には薬液をバ
ルーン1内に流入させたり、該バルーン1より薬液を所定
箇所に流出させる際に薬液の流路となる薬液通路が形成
されている。薬液通路には、図3〜図6に示されるように
バルーン1側からダックビルタイプの逆止弁14、固定デ
ィスク15およびシール手段16が設けられている。ダック
ビルタイプの逆止弁14は弁の閉鎖端がカモノハシの嘴の
ような形状をしており、バルーン1内部への薬液の流通
は許すが、その逆方向の流れは阻止する構造になってい
る。逆止弁14としては、前記ダックビルタイプの弁のほ
かにも傘弁、フラップ弁、ポペット弁、ボール弁などを
用いることができ、これらの弁材料としては弗素樹脂、
ナイロン、ポリオレフィン、ポリ塩化ビニル、ポリカー
ボネート、シリコーン樹脂などが挙げられる。固定ディ
スク15は逆止弁14の基板を支持するものであり、中央部
には薬液の流出流入のための開口部が形成されている。
開口部は薬液流出部および薬液流入部を兼用している。
図1〜図4の薬液注入器具における薬液流出は、図4に示
すように逆止弁14を連通パイプ12で開くことによって行
われるが、図8および図9に示すような薬液注入器具にお
いては、バルーン1内の薬液を栓体49に薬液流通チュー
ブ部fの端部にある注射針50が穿刺されて行われる。One end surface of the housing 2 is closed by a cap 13, and a central portion of the cap 13 is used to allow a chemical solution to flow into the balloon 1 or to allow the chemical solution to flow out of the balloon 1 to a predetermined location. A chemical liquid passage serving as a flow path is formed. As shown in FIGS. 3 to 6, a duckbill-type check valve 14, a fixed disk 15, and a sealing means 16 are provided in the chemical liquid passage from the balloon 1 side. The duck-bill type check valve 14 has a closed end of a valve-like shape of a platypus beak, which allows the drug solution to flow into the inside of the balloon 1 but prevents the flow in the reverse direction. . As the check valve 14, besides the duckbill type valve, an umbrella valve, a flap valve, a poppet valve, a ball valve, and the like can be used.
Examples include nylon, polyolefin, polyvinyl chloride, polycarbonate, and silicone resin. The fixed disk 15 supports the substrate of the check valve 14, and has an opening formed at the center thereof for outflow and inflow of the chemical solution.
The opening also serves as a drug solution outlet and a drug solution inlet.
1 to 4 is performed by opening the check valve 14 with the communication pipe 12 as shown in FIG. 4, but in the chemical injection device as shown in FIG. 8 and FIG. The medical solution in the balloon 1 is inserted into the stopper 49 by puncturing the injection needle 50 at the end of the medical solution flow tube portion f.
【0015】図3において、接続具であるロックアダプ
タ−11と固定デイスク15により形成された環状凹所18内
には、シ−ル手段16たるO−リングが配設されている。
このO−リングの内径は連通パイプの外径と同一もしく
はそれより小さく、これによって連通パイプ12を薬液通
路内に挿入したときのシ−ル性が高められるようになっ
ている。ロックアダプタ−11は内面がルア−テ−パ−状
に形成されたほぼ円筒状の接続具である。このロックア
ダプタ−11はハウジング2のキャップ13に形成された凹
所内に嵌め込まれている。ロックアダプタ−11の端部外
周には薬液流通チュ−ブbを接続するための突起部19が
形成されている。薬液のバル−ン1への流入は図5およ
び図6に示すように、薬液通路内に注射器のシリンジ21
を挿入し、このシリンジ21の針基22の外周をロックアダ
プタ−11のルア−テ−パ−状の内周面に嵌合し、ロック
アダプタ−11に形成された突起部19とシリンジ21のネジ
部23とを螺合して行う。図6ではシリンジ21の針基22は
ロックアダプタ−11と螺合するように形成されている
が、シリンジ21の針基22の外周をロックアダプタ−11の
ルア−テ−パ−状の内周面に押しつけながら薬液をバル
−ンに流入してもよい。この時、針基22は逆止弁14の入
口側にあり、その長さは逆止弁14に届かない範囲であ
り、バル−ン内への薬液充填時に薬液が薬液流通チュ−
ブb側へ逆流するのを防止する。In FIG. 3, an O-ring serving as a sealing means 16 is disposed in an annular recess 18 formed by a lock adapter 11 as a connecting tool and a fixed disk 15.
The inner diameter of the O-ring is equal to or smaller than the outer diameter of the communication pipe, so that the sealing performance when the communication pipe 12 is inserted into the chemical solution passage is improved. The lock adapter 11 is a substantially cylindrical connection tool having an inner surface formed in a luer taper shape. The lock adapter 11 is fitted in a recess formed in the cap 13 of the housing 2. On the outer periphery of the end portion of the lock adapter 11, a projection 19 for connecting the chemical solution distribution tube b is formed. As shown in FIGS. 5 and 6, the flow of the drug solution into the balloon 1 is set in the syringe 21 of the syringe in the drug solution passage.
And the outer periphery of the needle base 22 of the syringe 21 is fitted on the inner surface of the lock adapter 11 in the form of a luer taper, and the projection 19 formed on the lock adapter 11 and the syringe 21 are inserted. This is performed by screwing with the screw portion 23. In FIG. 6, the needle base 22 of the syringe 21 is formed so as to screw with the lock adapter 11, but the outer circumference of the needle base 22 of the syringe 21 is fixed to the inner circumference of the lock adapter 11 in the form of a luer taper. The chemical solution may flow into the balloon while being pressed against the surface. At this time, the needle base 22 is located on the inlet side of the check valve 14 and its length is in a range not reaching the check valve 14, and the chemical solution flows into the balun when the chemical solution is filled.
To prevent backflow to the b side.
【0016】図1において、薬液流通チュ−ブ部bは薬
液流出入部4のロックアダプタ−11と接続するコネクタ
−部6と、薬液量を制御するための流量制御部5と、薬
液流出チュ−ブ7と、接続具8とで構成されている。コ
ネクタ−部6の一端には図3に示すようにロックアダプ
タ−11に接続されたときに、逆止弁14を押し開いてバル
−ン1内部に連通しうる長さを有する連通パイプ12が設
けられている。この連通パイプ12はポリカ−ボネ−ト、
ポリ塩化ビニル、ポリオレフインなどの合成樹脂やステ
ンレスなどの金属で作製することができる。連通パイプ
12はコネクタ−部6の内周面に固着されている。連通パ
イプ12の突出部の長さは、図4にも示されるようにコネ
クタ−部6とロックアダプタ−11が接続されたときにダ
ックビルタイプの逆止弁14を押し広げうる長さに設定さ
れている。これにより逆止弁14の逆止効果が強制的に解
除されて、注入針を用いなくともバル−ン1内に充填さ
れた薬液の流出が可能になる。コネクタ−部側のネジ部
20はロックアダプタ−11に形成された突起部19との螺合
によりバル−ン部aと薬液流通チュ−ブbとの接続が行
われる。この接続は螺合以外に嵌合で行うようにしても
よい。In FIG. 1, a chemical solution flow tube portion b includes a connector portion 6 connected to the lock adapter 11 of the chemical solution inflow / outflow portion 4, a flow rate control portion 5 for controlling the amount of the chemical solution, and a chemical solution outflow tube. And a connector 8. At one end of the connector portion 6, as shown in FIG. 3, a communication pipe 12 having a length capable of pressing and opening the check valve 14 and communicating with the interior of the balloon 1 when connected to the lock adapter 11 is provided. Is provided. This communication pipe 12 is made of polycarbonate,
It can be made of a synthetic resin such as polyvinyl chloride or polyolefin or a metal such as stainless steel. Communication pipe
Reference numeral 12 is fixed to the inner peripheral surface of the connector portion 6. As shown in FIG. 4, the length of the projecting portion of the communication pipe 12 is set to such a length that the duckbill check valve 14 can be expanded when the connector portion 6 and the lock adapter 11 are connected. ing. As a result, the check effect of the check valve 14 is forcibly released, and the chemical solution filled in the balloon 1 can be flowed out without using an injection needle. Thread on connector side
Reference numeral 20 denotes a connection between the balloon portion a and the chemical liquid distribution tube b by screwing with a projection 19 formed on the lock adapter 11. This connection may be made by fitting other than screwing.
【0017】図7は流量制御部5の薬液上流側チュ−ブ
に定量弁10を配設した流量制御部5付近の説明図であ
る。流量制御部5は薬液の流量を制御する箇所であり、
例えば図7に示すような内径10〜 500μの微細内径のパ
イプを設置すると、バル−ン1内の薬液の流出速度が遅
くなり、人体への薬液注入時間を長くすることができ
る。パイプの長さは1cm以上で外径は内径の5〜 500倍
の大きさである。パイプの長さが30mmを越えると、図7
に示すような捲縮構造をした微細内径パイプ25を収納し
たケ−ス26を使用すると薬液流通チュ−ブbの長さが短
くなって好ましい。流量制御部5としては、本出願人が
既に出願した特開平2-11160 号公報あるいは特開平3-14
0163号公報に記載された金属製パイプ、合成樹脂製パイ
プ、ガラス製パイプなどが用いられることができる。FIG. 7 is an explanatory view of the vicinity of the flow control unit 5 in which the metering valve 10 is disposed in the tube on the chemical solution upstream side of the flow control unit 5. The flow control unit 5 is a part that controls the flow rate of the chemical solution,
For example, when a pipe having a fine inner diameter of 10 to 500 μm as shown in FIG. 7 is installed, the outflow speed of the chemical solution in the balloon 1 becomes slow, and the time for injecting the chemical solution into the human body can be lengthened. The length of the pipe is 1 cm or more, and the outer diameter is 5 to 500 times the inner diameter. When the length of the pipe exceeds 30mm,
It is preferable to use a case 26 accommodating a fine inner diameter pipe 25 having a crimped structure as shown in FIG. The flow rate control unit 5 is disclosed in Japanese Patent Application Laid-Open No. 2-11160 or 3-14
[0163] Metal pipes, synthetic resin pipes, glass pipes, and the like described in JP-A-163163 can be used.
【0018】流量制御部5の薬液上流側入口に定量弁10
を設けることによって、流量制御部5に流入する薬液量
をほぼ一定にすることができるので、更に正確に流量を
制御するとともに、ガス室9のガス量を長時間保持する
ことができる。図7の定量弁10は一例であるが、変形可
能なゴム状弾性体からなるオリフイス体30を固着する筒
状体32の薬液上流側に栓体33、薬液下流側にキャップ体
36が装着されており、オリフイス体30の弁孔31の前後
で、その同軸方向に薬液チュ−ブ38、39、薬液通路40、
41が配設された構造をしている。オリフイス体30は薬液
上流側から薬液下流側に通じる弁孔31を有し、該弁孔31
は弁孔入口から入った途中で内径が最小になり、該最小
位置から薬液下流側に行くに従って次第に内径が大きく
なった形状をしている。弁孔31の内径は所望する薬液流
出速度によって随意変更できる。オリフイス体30は筒状
体32の内壁に固着される。筒状体32の薬液流入側の内壁
には雌型螺子部34が形成され、栓体33の雄型螺子部35と
螺合し、栓体33を回転させることによってオリフイス体
30を押圧し、弁孔31の内径を調整する。弁孔31と薬液上
流側チュ−ブcとの間には、バル−ン1内の薬液に含有
されている微小物質を除去するためのフイルタ−37が設
けられていてもよい。フイルタ−37は薬液上流側チュ−
ブcの先端部に設置されるのが好ましく、繊維状物、焼
結物等が使用されるA fixed quantity valve 10 is provided at the inlet of the chemical liquid upstream side of the flow control unit 5.
Is provided, the amount of the chemical liquid flowing into the flow control unit 5 can be made substantially constant, so that the flow rate can be controlled more accurately and the gas amount in the gas chamber 9 can be maintained for a long time. The metering valve 10 shown in FIG. 7 is an example.
A chemical solution tube 38, 39, a chemical solution passage 40,
It has a structure where 41 are arranged. The orifice body 30 has a valve hole 31 communicating from the chemical solution upstream side to the chemical solution downstream side.
Has a shape in which the inside diameter is minimized on the way from the valve hole inlet, and gradually increases from the minimum position toward the downstream side of the chemical solution. The inner diameter of the valve hole 31 can be arbitrarily changed depending on a desired chemical outflow speed. The orifice body 30 is fixed to the inner wall of the cylindrical body 32. A female screw portion 34 is formed on the inner wall of the cylindrical body 32 on the side of the chemical liquid inflow, and is screwed with a male screw portion 35 of the plug 33, and the orifice body is formed by rotating the plug 33.
30 is pressed to adjust the inner diameter of the valve hole 31. Between the valve hole 31 and the chemical solution upstream tube c, a filter 37 for removing minute substances contained in the chemical solution in the balloon 1 may be provided. The filter 37 is a tube on the chemical solution upstream side.
It is preferably installed at the tip of the bush c, and a fibrous material, a sintered material, or the like is used.
【0019】栓体33はオリフイス体30の弁孔31の入口と
連通するための薬液上流側通路40と、該薬液上流側通路
40と連結した薬液上流側チュ−ブcが装着されており、
栓体33の先端部はオリフイス体30と接し、薬液上流側通
路40の出口とオリフイス体30の弁孔31の入口とは同軸方
向に連通している。栓体33の先端側面部には筒状体32の
雌型螺子部34と螺合する雄型螺子部35が形成されてお
り、栓体33を回転させることによって雄型螺子部35が雌
型螺子部34を移動してオリフイス体30の弁孔31の内径の
大きさを調整し薬液の流出速度を調節する。キャップ体
36はオリフイス体30の弁孔31の出口と連通するための薬
液下流側通路41と、該薬液下流側通路41と連結した薬液
下流側チュ−ブdが配設されている。キャップ体36の一
端はオリフイス体30と接し、筒状体32の内腔に嵌着さ
れ、薬液下流側通路41の入口とオリフイス体30の弁孔31
の出口とは同軸方向に連通している。The stopper 33 has a chemical solution upstream passage 40 for communicating with the inlet of the valve hole 31 of the orifice body 30, and a chemical solution upstream passage.
A chemical solution upstream tube c connected to 40 is mounted,
The tip of the plug 33 is in contact with the orifice body 30, and the outlet of the chemical liquid upstream passage 40 and the inlet of the valve hole 31 of the orifice body 30 are communicated coaxially. A male screw portion 35 that is screwed with the female screw portion 34 of the cylindrical body 32 is formed on the tip side surface portion of the plug 33, and the male screw portion 35 is turned into a female type by rotating the plug 33. By moving the screw portion 34, the size of the inner diameter of the valve hole 31 of the orifice body 30 is adjusted, and the outflow speed of the chemical solution is adjusted. Cap body
Reference numeral 36 denotes a chemical solution downstream passage 41 for communicating with the outlet of the valve hole 31 of the orifice body 30, and a chemical solution downstream tube d connected to the chemical solution downstream passage 41. One end of the cap body 36 is in contact with the orifice body 30 and is fitted into the inner cavity of the cylindrical body 32, and the inlet of the chemical solution downstream passage 41 and the valve hole 31 of the orifice body 30 are provided.
Communicates coaxially with the outlet.
【0020】図7の定量弁10において、オリフイス体30
のほぼ中央部には弁孔31が形成され、栓体33を回転させ
ることによって栓体33の先端はゴム状弾性体からなるオ
リフイス体30の環状足部を押圧し、弁孔31の内径が僅か
に変化して薬液流出速度が設定される。弁孔31は弁孔入
口から入った途中で内径が最小になり、該最小位置から
薬液下流側に行くに従って次第に内径が大きくなった形
状をしている。かかる状態で薬液上流側チュ−ブcから
薬液上流側通路40を経て供給された薬液は、オリフイス
体31の入口に形成された凹状空間部を経て弁孔31の入口
に達し、その入口に与える圧力によって弁孔31の内径の
最小位置が微妙に変化する。その結果、常時弁孔31の出
口から流出する薬液の圧力はほぼ一定に保たれる。In the metering valve 10 shown in FIG.
A valve hole 31 is formed at a substantially central portion of the valve body, and by rotating the plug body 33, the tip of the plug body 33 presses the annular foot of the orifice body 30 made of a rubber-like elastic body. The liquid outflow speed is set slightly. The valve hole 31 has such a shape that the inside diameter becomes minimum while entering from the valve hole entrance, and gradually increases from the minimum position toward the downstream side of the chemical solution. In this state, the chemical supplied from the chemical upstream tube c through the chemical upstream passage 40 reaches the inlet of the valve hole 31 through the concave space formed at the inlet of the orifice body 31 and is given to the inlet. The minimum position of the inner diameter of the valve hole 31 is slightly changed by the pressure. As a result, the pressure of the drug solution flowing out of the outlet of the valve hole 31 is always kept substantially constant.
【0021】オリフイス体30は変形可能なゴム状弾性体
からなる。ゴム状弾性体の材料としてはスチレン・ブタ
ジエンゴム、イソプレンゴム、アクリロニトリル・ブタ
ジエンゴム、ブタジエンゴム、オレフイン系ゴム、フッ
ソ系ゴム、シリコ−ンゴム、ウレタンゴム、クレイトン
ゴム、ペルプレンなどの合成ゴム、天然ゴムなどが挙げ
られる。弾性体の硬度はJIS-A 型によるスプリング式硬
さ試験機で測定した硬度が25〜70度、好ましくは35〜60
度である。硬度が25度未満であると、オリフイス体30が
薬液の圧力によって簡単に変形しすぎる傾向があり、弁
孔31の内径の調整が困難であり、硬度が70度を越えると
僅かの薬液流出圧力の変化に対してオリフイス体30が反
応せず、弁孔31の内径が変化しない傾向がある。弁孔31
の内径は所望する薬液流出速度によって任意に変更可能
であるが、通常は 100〜1000μが好ましい。The orifice body 30 is made of a deformable rubber-like elastic body. Examples of the rubber-like elastic material include synthetic rubbers such as styrene / butadiene rubber, isoprene rubber, acrylonitrile / butadiene rubber, butadiene rubber, olefin rubber, fluorine rubber, silicone rubber, urethane rubber, clayton rubber, perprene, and natural rubber. And the like. The hardness of the elastic body is a hardness measured by a JIS-A type spring hardness tester of 25 to 70 degrees, preferably 35 to 60 degrees.
Degrees. If the hardness is less than 25 degrees, the orifice body 30 tends to be easily deformed due to the pressure of the chemical solution, it is difficult to adjust the inner diameter of the valve hole 31, and if the hardness exceeds 70 degrees, there is a slight chemical outflow pressure. The orifice body 30 does not respond to the change of the diameter, and the inner diameter of the valve hole 31 does not change. Valve hole 31
Can be arbitrarily changed depending on the desired chemical outflow rate, but usually 100 to 1000 μm is preferable.
【0022】図1の薬液流通チュ−ブbにおいて、流量
制御部5は接続具8から離れた位置に設置される。流量
制御部5からその下流に位置する接続具8までの薬液下
流側チュ−ブdは、その内径が流量制御部5からその上
流に位置する薬液流出部方向へ延びた薬液上流側チュ−
ブcの内径に比較して小さい。薬液下流側チュ−ブdの
内径は薬液上流側チュ−ブcの内径に対して15%〜85
%、好ましくは30%〜70%である。薬液上流側チュ−ブ
cと薬液下流側チュ−ブdの内径の比率は、薬液下流側
チュ−ブdの長さによっても異なる。薬液下流側チュ−
ブdの長さは少なくとも30cmあるのが、腕の温度の影響
を受けなくて好ましい。In the chemical liquid distribution tube b shown in FIG. 1, the flow rate control unit 5 is installed at a position away from the connector 8. The chemical liquid downstream tube d from the flow control unit 5 to the connector 8 located downstream thereof has a chemical liquid upstream tube whose inner diameter extends from the flow control unit 5 toward the chemical liquid outflow unit located upstream thereof.
It is smaller than the inner diameter of the bush c. The inside diameter of the chemical solution downstream tube d is 15% to 85% of the inside diameter of the chemical solution upstream tube c.
%, Preferably 30% to 70%. The ratio of the inner diameter of the chemical solution upstream tube c to the chemical solution downstream tube d also varies depending on the length of the chemical solution downstream tube d. Chemical solution downstream tube
The length of the boss d is preferably at least 30 cm without being affected by the temperature of the arm.
【0023】薬液流通チュ−ブbは軟質ポリ塩化ビニ
ル、ポリプロピレン、ポリエステルなどからなり、その
他端にはルア−テ−パ−状の接続具8が設けられ、接続
具8を介して静脈針やPSVセットなどが接続される。
接続具8には静脈圧などにより薬液が逆流するのを防止
するための逆止弁(表示せず)を装備してもよい。な
お、本発明の薬液注入器具は、特公平3-55142号公報、
特表平1-501451号公報、特開平2-11160号公報、特開平
3-170163号公報等に記載された薬液注入器具にも使用さ
れることができる。The chemical distribution tube b is made of soft polyvinyl chloride, polypropylene, polyester, or the like, and a luer-taper-shaped connecting device 8 is provided at the other end. A PSV set or the like is connected.
The connector 8 may be provided with a check valve (not shown) for preventing the chemical solution from flowing backward due to venous pressure or the like. Note that the drug solution injection device of the present invention is disclosed in Japanese Patent Publication No. 3-55142,
JP-A-1-501451, JP-A-2-11160, JP-A-Hei.
It can also be used for a drug solution injector described in 3-170163 and the like.
【0024】[0024]
【発明の効果】本発明薬液注入器具は薬液をバル−ン内
に充填して膨張したバル−ンの外側から、該バル−ンの
収縮力より大きいガス圧でバル−ンを圧縮することによ
ってバル−ン内の薬液を患者に注入する機構であるの
で、ハウジング内のバル−ンの操作機構を従来の薬液注
入器具より簡略化して薬液を患者に注入することがで
き、薬液注入器具のコストを下げることができる。ま
た、流量制御部の薬液上流側入口に定量弁を設置するこ
とによって流量制御部に流入する薬液量をほぼ一定にす
ることができ、更に正確に薬液量を制御することができ
るとともにガス室のガス量を長時間保持することができ
患者への薬液の長時間注入が可能になる。The chemical injection device of the present invention fills a balloon with a chemical solution and compresses the balloon from the outside of the balloon with a gas pressure greater than the contraction force of the balloon. The mechanism for injecting the liquid medicine in the balloon into the patient allows the operation mechanism of the balloon in the housing to be simpler than that of the conventional liquid injector, thereby injecting the liquid into the patient. Can be lowered. Also, by installing a metering valve at the upstream side of the chemical solution of the flow control unit, the amount of the chemical solution flowing into the flow control unit can be made substantially constant, and the amount of the chemical solution can be controlled more accurately, and the gas chamber can be controlled. The gas amount can be maintained for a long time, and the drug solution can be injected into the patient for a long time.
【図1】本発明の薬液注入器具の一実施例の説明図。FIG. 1 is an explanatory view of one embodiment of a drug solution injector according to the present invention.
【図2】図1のバル−ンに薬液を充填したときのバル−
ン部の拡大断面図。FIG. 2 is a perspective view of a balloon when a chemical solution is filled in the balloon of FIG. 1;
FIG.
【図3】図1に示す薬液流通チュ−ブのコネクタ−とル
ア−テ−パ−状アダプタ−の拡大断面図。FIG. 3 is an enlarged sectional view of a connector and a luer taper adapter of the chemical liquid distribution tube shown in FIG. 1;
【図4】図3に示すコネクタ−をルア−テ−パ−状アダ
プタ−に挿入したときの状態を示す説明図。FIG. 4 is an explanatory view showing a state when the connector shown in FIG. 3 is inserted into a luer-tapered adapter.
【図5】シリンジ内薬液をバル−ンに注入するときの説
明図であってシリンジとバル−ン部が接続していない状
態を示す説明図。FIG. 5 is an explanatory view when injecting the drug solution in the syringe into the balloon, and is an explanatory view showing a state where the syringe and the balloon section are not connected.
【図6】図5に示すシリンジから薬液をバル−ン内へ充
填しているときの説明図。FIG. 6 is an explanatory view when a chemical is filled into the balloon from the syringe shown in FIG. 5;
【図7】流量制御部の薬液上流側チュ−ブに定量弁を配
設した流量制御部付近の説明図。FIG. 7 is an explanatory view showing the vicinity of a flow rate control unit in which a metering valve is arranged in a tube on a chemical solution upstream side of the flow rate control unit.
【図8】特開平4-67873号公報に記載されている薬液注
入器具の全体説明図。FIG. 8 is an overall explanatory view of a drug solution injector described in Japanese Patent Application Laid-Open No. 4-67873.
【図9】図8に示すハウジングのバル−ンに薬液を充填
した時の状態を示す拡大断面図。FIG. 9 is an enlarged cross-sectional view showing a state where the balloon of the housing shown in FIG. 8 is filled with a chemical solution.
a バル−ン部 b 薬液流通チュ−ブ部 1 バル−ン 2 ハウジング 3 ガス注入部 4 薬液流出入部 5 流量制御部 6 コネクタ−部 7 チュ−ブ 8 接続具 9 ガス室 10 定量弁 11 ロックアダプタ− 12 連通パイプ 14 逆止弁 30 オリフイス体 31 弁孔 32 筒状体 33 栓体 34 雌型螺子部 35 雄型螺子部 36 キャップ体 37 フイルタ− a balloon section b chemical liquid circulation tube section 1 balloon 2 housing 3 gas injection section 4 chemical liquid inflow / outflow section 5 flow rate control section 6 connector section 7 tube 8 connector 9 gas chamber 10 metering valve 11 lock adapter − 12 Communication pipe 14 Check valve 30 Orifice body 31 Valve hole 32 Cylindrical body 33 Plug body 34 Female screw part 35 Male screw part 36 Cap body 37 Filter
Claims (7)
ら薬液を流入および流出させるバルーンと、該バルーン
を収納し、バルーンの外側が薬液を充填したバルーンの
圧力より高い圧力で加圧されたガスが充填されたガス室
とからなるハウジングと、該ハウジングを形成する壁に
設置された前記バルーンの開口部を固着した薬液流入部
および/または薬液流出部とガス注入口と、前記薬液流
出部から延びた薬液流通チューブと、該薬液流通チュー
ブに配置された薬液量を制御するための流量制御部とか
らなる薬液注入器具であって、前記流量制御部の薬液上
流側には定量弁が設けられてなる薬液注入器具。1. A balloon for storing a medicinal solution in a pressurized state and for allowing the medicinal solution to flow in and out of an opening, and a balloon containing the balloon, wherein the outside of the balloon is pressurized at a pressure higher than the pressure of the balloon filled with the medicinal solution. A gas chamber filled with the filled gas, a chemical liquid inlet and / or a chemical liquid outlet to which an opening of the balloon provided on a wall forming the housing is fixed, and a gas inlet, A drug solution injection device comprising: a drug solution flow tube extending from an outflow portion; and a flow rate control portion for controlling the amount of the drug solution arranged in the drug solution flow tube.
A chemical injection device provided with a metering valve on the outflow side .
可塑性樹脂からなる請求項1記載の薬液注入器具。2. The liquid injector according to claim 1 , wherein the balloon material is made of an elastic rubber or a thermoplastic resin.
有するゴム状弾性体からなるオリフィス体と、該弁孔の
内径を調整するための調整手段とからなる、請求項1記
載の薬液注入器具。 Wherein said shutoff valve includes an orifice body made of a rubber-like elastic material having an inner diameter of deformable valve hole, and a adjusting means for adjusting the inner diameter of the valve hole, according to claim 1, wherein Drug injection device.
体積は、人体に注入すべき薬液量の薬液を充填させたと
きのバルーンの占める体積の少なくとも0.2倍である、
請求項1〜3のいずれかに記載の薬液注入器具。 Volume 4. A occupied by the gas chamber in the housing is at least 0.2 times the volume occupied by the balloon when is filled with chemical solution amount of liquid medicine to be injected into the human body,
The drug solution injector according to any one of claims 1 to 3 .
細内径のパイプからなる、請求項1〜4のいずれかに記
載の薬液注入器具。 Wherein said flow controller is composed of a pipe of the fine inner diameter of the inner diameter of 10 to 500, the drug solution injector according to any one of claims 1-4.
は、薬液上流側の最小位置から薬液下流側に行くに従っ
て次第に大きくなる、請求項3記載の薬液注入器具。 6. An inner diameter of a valve hole of an orifice body of the metering valve.
It is gradually increased toward the liquid chemical downstream from the minimum position of the chemical liquid upstream, liquid injection device according to claim 3, wherein.
の調整手段は、オリフィス体を配設した筒状体の薬液上
流側の内壁に形成された螺子部と、前記弁孔入口と連通
するための薬液上流側通路を有する栓体の外壁に形成さ
れた螺子部とが螺合されてなる、請求項3記載の薬液注
入器具。Adjusting means for adjusting the inner diameter of 7. The valve hole of the shutoff valve includes a threaded portion formed in the chemical upstream of the inner wall of the orifice member is disposed a cylindrical body, and the valve hole inlet The drug solution injection device according to claim 3 , wherein a screw portion formed on an outer wall of the plug having a drug solution upstream side passage for communication is screwed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP05113903A JP3120922B2 (en) | 1993-04-16 | 1993-04-16 | Chemical injection device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP05113903A JP3120922B2 (en) | 1993-04-16 | 1993-04-16 | Chemical injection device |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06296688A JPH06296688A (en) | 1994-10-25 |
JP3120922B2 true JP3120922B2 (en) | 2000-12-25 |
Family
ID=14624059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP05113903A Expired - Fee Related JP3120922B2 (en) | 1993-04-16 | 1993-04-16 | Chemical injection device |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3120922B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1066845A1 (en) * | 1999-01-12 | 2001-01-10 | Tsukada Medical Research Co., Ltd. | Continuous transfusion injection unit assembly |
JP4653670B2 (en) * | 2006-02-06 | 2011-03-16 | 株式会社東芝 | Piping work device and work method |
KR20240005154A (en) | 2017-12-08 | 2024-01-11 | 후지모리 고교 가부시키가이샤 | Package |
-
1993
- 1993-04-16 JP JP05113903A patent/JP3120922B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH06296688A (en) | 1994-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5178610A (en) | Liquid infusion device | |
KR960012362B1 (en) | Liquid infusion device | |
JP3229833B2 (en) | Fluid transfer device | |
US5059182A (en) | Portable infusion device | |
KR970005840B1 (en) | Continuous drug solution injector equipped with balloon | |
WO1990014115A1 (en) | Balloon-carrying instrument for use in continuously injecting medical fluid | |
WO2003024503A2 (en) | Device and method for accurate delivery of an active agent | |
JP4539382B2 (en) | Patient controlled analgesia (PCA) device with continuous infusion and additional administration | |
JPH0871162A (en) | Medicinal liquid injecting appliance | |
JP2002058739A (en) | One shot injector of liquid medicine and liquid medicine injecting device | |
JP3120922B2 (en) | Chemical injection device | |
JP3102173B2 (en) | Chemical injection device | |
JPH042360A (en) | Balloon infuser | |
CN211986537U (en) | Infusion device | |
JPH10113385A (en) | Liquid medicine continuous injection device | |
JP3245841B2 (en) | Chemical injection device | |
JPH0687898B2 (en) | Balloon infusor | |
JP2725557B2 (en) | Chemical injection device | |
JPH1147271A (en) | Constant injector | |
JP2586275B2 (en) | Chemical injection tool | |
JP3087266B2 (en) | Chemical injection device | |
WO1995031240A1 (en) | Biassed liquid delivery valve arrangement | |
JP2637579B2 (en) | Balloon infuser | |
JP2598529B2 (en) | Balloon infuser | |
JP3109192B2 (en) | Balloon Infuser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091020 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101020 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111020 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121020 Year of fee payment: 12 |
|
LAPS | Cancellation because of no payment of annual fees |